Immunovant, Inc. Gains 97.04%
Tue, Sep 26, 2023 at 07:59 PM
Immunovant, Inc. (IMVT:NASDAQ) rocketted at $39.96, a gain of 97%. On Tue, Sep 26, 2023, IMVT:NASDAQ touched a New 2-Week High of $39.96. The stock got featured on our News Catalysts scanner on Tue, Sep 26, 2023 at 04:29 PM in the 'MISCELLANEOUS' category. From Tue, Sep 12, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
About Immunovant, Inc. (IMVT:NASDAQ)
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
Top 10 Gainers:
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 504.97%
- Femasys Inc. (FEMY:NASDAQ), 346.32%
- Signature Bank (SBNY:NASDAQ), 105.88%
- Immunovant, Inc. (IMVT:NASDAQ), 97.04%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ), 79.21%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 64.71%
- DMK Pharmaceuticals Corp Com Par $0.001 (DMK:NASDAQ), 59.25%
- Minerva Surgical Inc. (UTRS:NASDAQ), 55.22%
- Acasti Pharma Inc. (ACST:NASDAQ), 37.71%